CNE100001237
CNE100001237
STAIDSON BIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.18B EUR | 11.36B EUR | 14.35B EUR | 13.05B EUR |
Enterprise Value | 9.89B EUR | 11.39B EUR | 14.34B EUR | 13.01B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 26.83x | -- | -- | -- |
Price to Sales | 59.64x | 85.69x | 96.31x | 78.97x |
Price to Book | 12.23x | 14.08x | 17.72x | 15.9x |
EV/Revenue | 52.74x | 85.87x | 96.25x | 78.71x |
EV/EBITDA | -159.56x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.37% | -1.22% | -1.14% | -1.13% |